Agilent Technologies unveiled a new framework for next-generation sequencing (NGS) library preparation in February 2019 with the aim of efficiently running challenging DNA sequencing assays. The completely automated Magnis NGS preparation system has reagents and protocols that enable quick analyses of several genetic and structural abnormalities, even in samples with deteriorated quality like formalin-fixed paraffin-embedded (FFPE). The company has increased product exposure and attracted more market attention thanks to the announcement.
To develop a quick NGS-based diagnostics technique for the detection of COVID-19, Beckman Coulter Inc., Fry Laboratories LLC, and BioID Genomics Inc. entered into a collaboration agreement in August 2020.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5319
Published Date: Oct 17, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing prevalence of cancer & infectious diseases and growing drug development are some of the major factors anticipated to drive the growth of the DNA library preparation market.
The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2024-2036.
The major players in the market are of Swift Biosciences Inc., Merck KGaA, New England Biolabs, Inc., Hamilton Company, Eppendorf AG, Beckman Coulter Inc., Promega Corporation., and others.
The diagnostic segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.